Cancer

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: The validity of survival estimates from cancer registry data depends, in part, on the identification of the deaths of deceased cancer patients. People whose deaths are missed seemingly live on forever and are informally referred to as “immortals”, and their presence in registry data can result in inflated survival estimates. This study assesses the issue of immortals in the Canadian Cancer Registry (CCR) using a recently proposed method that compares the survival of long-term survivors of cancers for which “statistical” cure has been reported with that of similar people from the general population.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: According to recent Canadian estimates, over two in five Canadians will likely develop cancer in their lifetime, and one in four is expected to die of it. The lifetime probabilities of developing cancer and dying from cancer are useful summary statistics that describe the impact of cancer within a population. However, there is little information on how lifetime probabilities of developing cancer and dying from cancer have changed over time. This study aims to present detailed lifetime probabilities of developing cancer and dying from cancer by sex and cancer type, and to describe changes in these lifetime probabilities over time among the Canadian population.

Description:

Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

Description:

Number and rate of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage of cancer at diagnosis is an important determinant of survival, reflecting the extent and spread at the time of disease detection. The recent extension of the Canadian Cancer Registry death-linked analytic file from 2014 to 2017 now offers an opportunity to provide more up-to-date net survival (NS) figures and to profile, for the first time, five-year NS estimates for Canada (excluding Quebec). This study presents five-year stage-specific cancer and five-year NS estimates for the most commonly diagnosed cancers in Canada.

Description:

Number of new cases and age-standardized rates of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

An evaluation of progress in cancer survival in Canada for all cancer types combined was recently conducted using the cancer survival index. This study provides a comprehensive evaluation of provincial-level progress in cancer survival for all cancer types combined in Canada.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description:

Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

Description:

Number and rate of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

Number of new cases and age-standardized rates of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

Number and proportion of prevalent cancer cases for two-, five-, ten- and twenty-year prevalence durations from January 1st,1994 to the most recent index date available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

Annual percent change and average annual percent change in age-standardized cancer mortality rates since 1984 to the most recent data year. The table includes a selection of commonly diagnosed invasive cancers and causes of death are defined based on the World Health Organization International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1999 and on its tenth revision (ICD-10) from 2000 to the most recent year.

Description:

National estimates of five-year net survival for 56 types of cancer by age group at diagnosis. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description:

National estimates of five-year net survival for 12 types of cancer by age group at diagnosis. The age distributions of cases of these cancers are skewed toward older ages. Net survival refers to the survival probability that would be observed in the hypothetical situation where the cancer of interest is the only possible cause of death.

Description: The validity of survival estimates from cancer registry data depends, in part, on the identification of the deaths of deceased cancer patients. People whose deaths are missed seemingly live on forever and are informally referred to as “immortals”, and their presence in registry data can result in inflated survival estimates. This study assesses the issue of immortals in the Canadian Cancer Registry (CCR) using a recently proposed method that compares the survival of long-term survivors of cancers for which “statistical” cure has been reported with that of similar people from the general population.

Description: According to recent Canadian estimates, over two in five Canadians will likely develop cancer in their lifetime, and one in four is expected to die of it. The lifetime probabilities of developing cancer and dying from cancer are useful summary statistics that describe the impact of cancer within a population. However, there is little information on how lifetime probabilities of developing cancer and dying from cancer have changed over time. This study aims to present detailed lifetime probabilities of developing cancer and dying from cancer by sex and cancer type, and to describe changes in these lifetime probabilities over time among the Canadian population.

Description: Cancer survival estimates provide insights into the effectiveness of early detection and treatment. The stage of cancer at diagnosis is an important determinant of survival, reflecting the extent and spread at the time of disease detection. The recent extension of the Canadian Cancer Registry death-linked analytic file from 2014 to 2017 now offers an opportunity to provide more up-to-date net survival (NS) figures and to profile, for the first time, five-year NS estimates for Canada (excluding Quebec). This study presents five-year stage-specific cancer and five-year NS estimates for the most commonly diagnosed cancers in Canada.

Description:

An evaluation of progress in cancer survival in Canada for all cancer types combined was recently conducted using the cancer survival index. This study provides a comprehensive evaluation of provincial-level progress in cancer survival for all cancer types combined in Canada.

Description:

This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.

Description:

This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.

Description:

Cancer incidence rates have been shown to vary by ethnicity, and the increasing awareness of and interest in reporting ethnic health inequalities have been growing internationally. The objective of this study was to assess cancer incidence and mortality rates by ethnicity in Canada. The study used the 2006 Canadian Census Health and Environment Cohort, linked to the Canadian Cancer Registry and the Canadian Vital Statistics-Death Database, to determine cancer cases and mortality from 2006 to 2016. Ethnicity was categorized as non-Indigenous North American (NINA); European; Caribbean; Latin, Central and South American (LCSA); African; East Asian; South Asian; and West Central Asian and Middle Eastern.

Description:

Colorectal cancer screening, along with other health care services, was suspended in Canada in the initial phase of the COVID-19 pandemic response. This pause was deemed necessary to allow health care facilities to establish appropriate infection-control measures to prevent COVID-19 outbreaks and to reserve health system capacity for COVID-19 patients. The current article projects the impact of a three-month suspension of screening for colorectal cancer using a fecal test for average-risk individuals, and compares strategies to minimize the harm from screening interruptions. The projections come from OncoSim, a cancer microsimulation model co-developed by Statistics Canada and the Canadian Partnership Against Cancer.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description:

This study aims to measure cancer incidence and mortality rates of Registered First Nations people in Ontario and to look at trends over time, particularly in cancer rates that are targeted by screening programs (cervical, breast, colorectal) or public health interventions (smoking). The federal Indian Register, the Ontario Cancer Registry and the Registered Persons Database were linked to develop a cohort of First Nations people diagnosed with cancer in Ontario.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

Description:

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

Description:

This document examines the functional limitations - physical, emotional and social -experienced by patients at the time of diagnosis of cancer and as they undergo various treatments, remission, and palliative and terminal care. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with cancer affects day-to-day functioning.